Kim, who received the Marion B. Sulzberger Award at the 2024 American Academy of Dermatology Annual Meeting, discussed itch research an implications for clinical practice.
Brian Kim, M.D., MTR
Advertisement
Articles by Brian Kim, M.D., MTR
Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.
Advertisement
Latest Updated Articles
Nuogen Pharma: Innovation in the fight against itchMarch 30th 2020
Advertisement
Advertisement
Trending on Dermatology Times
1
Dermalogica Enters Medical Aesthetics with FDA-Cleared Microneedling PRO Pen
2
Social Media Mythbusters: Hypochlorous Acid Sprays
3
SkinJect Advances into Registrable Development as Potential First-in-Class Therapy for Gorlin Syndrome
4
Quoin Submits First-Ever IND Application for Peeling Skin Syndrome Therapy
5